These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney. Shelton BA; Sawinski D; Mehta S; Reed RD; MacLennan PA; Locke JE Transpl Infect Dis; 2018 Apr; 20(2):e12829. PubMed ID: 29277956 [TBL] [Abstract][Full Text] [Related]
4. Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. Reese PP; Shults J; Bloom RD; Mussell A; Harhay MN; Abt P; Levine M; Johansen KL; Karlawish JT; Feldman HI Am J Kidney Dis; 2015 Nov; 66(5):837-45. PubMed ID: 26162652 [TBL] [Abstract][Full Text] [Related]
5. Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients. Sageshima J; Troppmann C; McVicar JP; Santhanakrishnan C; de Mattos AM; Perez RV Transplantation; 2018 Jul; 102(7):1179-1187. PubMed ID: 29953423 [TBL] [Abstract][Full Text] [Related]
6. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients. Kucirka LM; Peters TG; Segev DL Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841 [TBL] [Abstract][Full Text] [Related]
7. Kidney transplantation in hepatitis C-positive recipients: does type of induction influence outcomes? Sureshkumar KK; Thai NL; Marcus RJ Transplant Proc; 2012 Jun; 44(5):1262-4. PubMed ID: 22663997 [TBL] [Abstract][Full Text] [Related]
8. Sex Disparities in Risk of Mortality Among Children With ESRD. Ahearn P; Johansen KL; McCulloch CE; Grimes BA; Ku E Am J Kidney Dis; 2019 Feb; 73(2):156-162. PubMed ID: 30318132 [TBL] [Abstract][Full Text] [Related]
9. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. Rabbat CG; Thorpe KE; Russell JD; Churchill DN J Am Soc Nephrol; 2000 May; 11(5):917-922. PubMed ID: 10770970 [TBL] [Abstract][Full Text] [Related]
10. Deceased-donor characteristics and the survival benefit of kidney transplantation. Merion RM; Ashby VB; Wolfe RA; Distant DA; Hulbert-Shearon TE; Metzger RA; Ojo AO; Port FK JAMA; 2005 Dec; 294(21):2726-33. PubMed ID: 16333008 [TBL] [Abstract][Full Text] [Related]
11. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives? Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338 [TBL] [Abstract][Full Text] [Related]
12. Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Schold JD; Buccini LD; Goldfarb DA; Flechner SM; Poggio ED; Sehgal AR Clin J Am Soc Nephrol; 2014 Oct; 9(10):1773-80. PubMed ID: 25237071 [TBL] [Abstract][Full Text] [Related]
13. Transplantation of Patients With Long Dialysis Vintage in the Current Deceased Donor Kidney Allocation System (KAS). Kadatz M; Lan JH; Brar S; Vaishnav S; Chang DT; Gill J; Gill JS Am J Kidney Dis; 2022 Sep; 80(3):319-329.e1. PubMed ID: 35311661 [TBL] [Abstract][Full Text] [Related]
14. Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes. Gill JS; Rose C; Joffres Y; Landsberg D; Gill J Am J Kidney Dis; 2018 May; 71(5):636-647. PubMed ID: 29395484 [TBL] [Abstract][Full Text] [Related]
15. Duration of end-stage renal disease and kidney transplant outcome. Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892 [TBL] [Abstract][Full Text] [Related]
16. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066 [TBL] [Abstract][Full Text] [Related]
17. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407 [TBL] [Abstract][Full Text] [Related]
18. Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist. Cohen JB; Eddinger KC; Locke JE; Forde KA; Reese PP; Sawinski DL Clin J Am Soc Nephrol; 2017 Jun; 12(6):974-982. PubMed ID: 28546439 [TBL] [Abstract][Full Text] [Related]
20. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Molnar MZ; Streja E; Kovesdy CP; Shah A; Huang E; Bunnapradist S; Krishnan M; Kopple JD; Kalantar-Zadeh K Am J Kidney Dis; 2012 Jun; 59(6):841-8. PubMed ID: 22305759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]